References
- World Health Organization. Adherence to long-term therapies: evidence for action [Internet]. Geneva (Switzerland): WHO; 2003 [cited 2019 March 18]. Available from: https://apps.who.int/iris/bitstream/handle/10665/42682/9241545992.pdf;jsessionid=B236F008ABD194E73BD9FD586C666EAB?sequence=1
- Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497.
- Hugtenburg JG, Timmers L, Elders PJM, et al. Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions. Patient Prefer Adher. 2013;7:675–682.
- Naqvi AA, Hassali MA, Aftab MT, et al. A qualitative study investigating perceived barriers to medication adherence in chronic illness patients of Karachi, Pakistan. J Pak Med Assoc. 2019;69(2):216–223.
- Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47(6):555–567.
- Horne R, Parham R, Driscoll R, et al. Patients’ attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis. 2009;15(6):837–844.
- Horne R, Chapman SC, Parham R, et al. Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLoS One. 2013;8(12):e80633.
- Krauskopf K, Federman AD, Kale MS, et al. Chronic obstructive pulmonary disease illness and medication beliefs are associated with medication adherence. COPD. 2015;12(2):151–164.
- Brandstetter S, Finger T, Fischer W, et al. Differences in medication adherence are associated with beliefs about medicines in asthma and COPD. Clin Transl Allergy. 2017;7(1):39.
- Park HY, Seo SA, Yoo H, et al. Medication adherence and beliefs about medication in elderly patients living alone with chronic diseases. Patient Pref Adher. 2018;12:175–181.
- Naqvi AA, Hassali MA, Rizvi M, et al. Development and validation of a novel General Medication Adherence Scale (GMAS) for chronic illness patients in Pakistan. Front Pharmacol. 2018;9(9):1124.
- Naqvi AA, Hassali MA, Jahangir A, et al. Translation and validation of the English version of the general medication adherence scale (GMAS) in patients with chronic illnesses. J Drug Assess. 2019;8(1):36–42.
- Borgsteede SD, Westerman MJ, Kok IL, et al. Factors related to high and low levels of drug adherence according to patients with type 2 diabetes. Int J Clin Pharm. 2011;33(5):779–787.
- Fortuna RJ, Nagel AK, Rocco TA, et al. Patient experience with care and its association with adherence to hypertension medications. Am J Hypertens. 2018;31(3):340–345.
- Orozco-Beltrán D, de Toro J, Galindo MJ, et al. Healthcare experience and their relationship with demographic, disease and healthcare-related variables: a cross-sectional survey of patients with chronic diseases using the IEXPAC Scale. Patient. 2019;12(3):307–317.
- Mira JJ, Nuño-Solinís R, Guilabert-Mora M, et al. Development and validation of an instrument for assessing patient experience of chronic illness care. Int J Integr Care. 2016;16(3):13.
- Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1–24.
- Beléndez-Vázquez M, Hernández-Mijares A, Horne R, et al. Evaluación de las creencias sobre el tratamiento: Validez y fiabilidad de la versión Española del Beliefs about Medicines Questionnaire [Factor structure and reliability of the Spanish version of the Beliefs about Medicines Questionnaire]. Int J Clin Health Psychol. 2007;7:767–779.
- Oung AB, Kosirog E, Chavez B, et al. Evaluation of medication adherence in chronic disease at a federally qualified health center. Ther Adv Chronic Dis. 2017;8(8–9):113–120.
- DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200–209.
- Ortego C, Huedo-Medina TB, Llorca J, et al. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011;15(7):1381–1396.
- Pagès-Puigdemont N, Mangues M, Masip M, et al. Patients’ perspective of medication adherence in chronic conditions: a qualitative study. Adv Ther. 2016;33(10):1740–1754.
- The Chronic Care Model [Internet]. The MacColl Institute. ACP-ASIM Journals and Books. 2019 [cited 2019 May 10]. Available from http://www.improvingchroniccare.org/index.php?p=The_Chronic_Care_Model&s=2
- von Birgelen C, Kok MM, Sattar N, et al. “Silent” diabetes and clinical outcome after treatment with contemporary drug-eluting stents: the BIO-RESORT Silent Diabetes Study. JACC Cardiovasc Interv. 2018;11(5):448–459.
- Aiuti F, Ensoli F, Fiorelli V, et al. Silent HIV infection. Vaccine. 1993;11(5):538–541.
- Allemann S, Nieuwlaat R, van den Bemt B, et al. Matching adherence interventions to patient determinants using the Theoretical Domains Framework. Front Pharmacol. 2016;7:429.
- Forbes CA, Deshpande S, Sorio-Vilela F, et al. A systematic literature review comparing methods for the measurement of patient persistence and adherence. Curr Med Res Opin. 2018;34(9):1613–1625.